Apellis Pharmaceuticals, Inc. (APLS) vs BridgeBio Pharma, Inc. (BBIO)

Detailed comparison between Apellis Pharmaceuticals, Inc., BridgeBio Pharma, Inc..

Total Return (%)

Apellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
May 2024Jun 2024Jul 2024Aug 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Dec 2024Jan 2025Feb 2025Mar 2025Apr 2025May 2025-60.00%-30.00%0.00%30.00%60.00%ROI (%)
  • Apellis Pharmaceuticals, Inc.
  • BridgeBio Pharma, Inc.

Which stock do you think will perform better?

Apellis Pharmaceuticals, Inc.

APLS

BridgeBio Pharma, Inc.

BBIO

MetricApellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
Current Price$17.52$35.68
Change0.22 (1.27%)1.51 (4.42%)
Market Cap$2.20B$6.77B
Trailing P/E0.000.00
Forward P/E-20.86-11.66
Dividend Yield0.00%0.00%
52-Week High$43.99$39.54
52-Week Low$16.65$21.62
Beta0.000.00
Earnings Per Share$-1.60$-3.56

Processing data. Please try again later.

Average Return

1 MonthYear-to-date1 Year5 Years10 YearsMax-60.00%-30.00%0.00%30.00%60.00%
  • Apellis Pharmaceuticals, Inc.
  • BridgeBio Pharma, Inc.
Symbol1 MonthYear-to-date1 Year5 Years10 YearsMax
APLS-9.36%-36.73%-57.48%-42.25%24.88%24.88%
BBIO2.38%0.21%23.25%16.60%29.51%29.51%